1. Home
  2. VIR vs FCF Comparison

VIR vs FCF Comparison

Compare VIR & FCF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIR
  • FCF
  • Stock Information
  • Founded
  • VIR 2016
  • FCF 1934
  • Country
  • VIR United States
  • FCF United States
  • Employees
  • VIR N/A
  • FCF N/A
  • Industry
  • VIR Biotechnology: Pharmaceutical Preparations
  • FCF Major Banks
  • Sector
  • VIR Health Care
  • FCF Finance
  • Exchange
  • VIR Nasdaq
  • FCF Nasdaq
  • Market Cap
  • VIR 1.4B
  • FCF 1.7B
  • IPO Year
  • VIR 2019
  • FCF N/A
  • Fundamental
  • Price
  • VIR $9.70
  • FCF $16.91
  • Analyst Decision
  • VIR Buy
  • FCF Buy
  • Analyst Count
  • VIR 6
  • FCF 7
  • Target Price
  • VIR $34.83
  • FCF $19.36
  • AVG Volume (30 Days)
  • VIR 3.8M
  • FCF 712.6K
  • Earning Date
  • VIR 02-20-2025
  • FCF 01-28-2025
  • Dividend Yield
  • VIR N/A
  • FCF 3.11%
  • EPS Growth
  • VIR N/A
  • FCF N/A
  • EPS
  • VIR N/A
  • FCF 1.39
  • Revenue
  • VIR $78,618,000.00
  • FCF $448,502,000.00
  • Revenue This Year
  • VIR N/A
  • FCF N/A
  • Revenue Next Year
  • VIR N/A
  • FCF $6.29
  • P/E Ratio
  • VIR N/A
  • FCF $12.03
  • Revenue Growth
  • VIR N/A
  • FCF N/A
  • 52 Week Low
  • VIR $6.56
  • FCF $12.41
  • 52 Week High
  • VIR $14.45
  • FCF $19.96
  • Technical
  • Relative Strength Index (RSI)
  • VIR 52.17
  • FCF 52.15
  • Support Level
  • VIR $10.09
  • FCF $16.11
  • Resistance Level
  • VIR $11.39
  • FCF $16.80
  • Average True Range (ATR)
  • VIR 0.71
  • FCF 0.40
  • MACD
  • VIR -0.11
  • FCF 0.08
  • Stochastic Oscillator
  • VIR 16.57
  • FCF 74.78

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

About FCF First Commonwealth Financial Corporation

First Commonwealth Financial Corp functions in the financial services sector in the United States. Through its subsidiary, it offers a range of consumer and commercial banking services such as personal checking accounts, interest-earning checking accounts, savings accounts, insured money market accounts, investment certificates, fixed & variable rate certificates of deposit, and various kinds of loans. It also provides trust and wealth management services and offers insurance products. The company earns the majority of its revenue through net interest income.

Share on Social Networks: